Is it worth it? Putting patient voice at the heart of healthtech testing
A Talk by Jenni Parker and Ali Fawkes
Register To Watch This Content
About this Talk
In this case study, Humanly will present its work with Asthma + Lung UK to design and deliver an Innovation Accelerator programme to identify and support healthtech innovations that support people with lung conditions to 'move more'.
Humanly's role centred on the meaningful involvement of people living with lung conditions, in both the testing of respiratory innovations and the co-design of the accelerator programme itself.
A co-design team that included designers, charity professionals, and people living with lung conditions worked together to deliver this 12-month project, during which 2 innovative healthtech products were tested with 36 highly diverse individuals. The 8-week testing phase was centred around a mobile ethnography study, where participants recorded their day-to-day experiences of managing their condition and using the products.
We will share the approach taken, the value of this approach, and the impact of the programme. By sharing our learning we hope to see more effective product development practices across the healthtech space, that marry usability and desirability with clinical efficacy. We believe this will lead to greater uptake of health innovations, and ultimately better outcomes for users.